Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Summit Nuclear — Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

139 daysmedian FDA review time
171 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K935273VISION FX 40 & 80 SERIES GAMMA CAMERASummit Nuclear1994-04-181672
K935318SUMMIT NUCLEAR VISION FX 20 SERIES GAMMA CAMERA SYSTEMSSummit Nuclear1994-02-251130
K922427SUMMIT NUCLEAR VISION 1024RZ GAMMA CAMERA SYSTEMSummit Nuclear1992-09-291300
K922426SUMMIT NUCLEAR VISION T-22 GAMMA CAMERA SYSTEMSummit Nuclear1992-09-281290
K920958SUMMIT NUCLEAR VISION NEUROSPECTSummit Nuclear1992-08-071710
K912573VISION (NUCLEAR MEDICINE COMPUTER)Summit Nuclear1991-10-281390

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda